Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cells and Fat Grafting for Breast Cancer-related Lymphedema
NCT03776721Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Dec 2018
- Primary completion
- Jun 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous adipose-derived stem/stromal cells in breast cancer-related lymphedema (BCRL) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Change in arm volume at 12 months. Started Dec 2018; status: completed.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
breast cancer-related lymphedema (BCRL)
Beyond the preview
Go deeper on NCT03776721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03776721.